S A Gregory

2.6k citations

22 papers · 2.2k indexed · h-index 17

Co-authors: Thomas S. Edgington Peter C. Isakson Graham Anderson Scott D. Hauser James H. Morrissey Karen Seibert Neal Nathanson John W. Balliet
Topics: Inflammatory mediators and NSAID effects (6 papers)Macrophage Migration Inhibitory Factor (3 papers)Synthesis and biological activity (2 papers)
Cited by: Virology Hematology Pharmacology
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Investigation The Journal of Experimental Medicine
Partner nations: United States United Kingdom Finland

In The Last Decade

S A Gregory

21 papers receiving 2.1k citations

Peers

Countries citing papers authored by S A Gregory

Since Specialization

Citations

This map shows the geographic impact of S A Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S A Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S A Gregory more than expected).

Fields of papers citing papers by S A Gregory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S A Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S A Gregory. The network helps show where S A Gregory may publish in the future.

Co-authorship network of co-authors of S A Gregory

This figure shows the co-authorship network connecting the top 25 collaborators of S A Gregory. A scholar is included among the top collaborators of S A Gregory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S A Gregory. S A Gregory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hyperhemolysis Syndrome Complicated by Acute Pulmonary Hypertension and Right Ventricular Failure in a Patient with Sickle Cell Disease 2021 ·(unknown),Simon P. Hart,S A Gregory	0
2	Evaluation of Accelerator Mass Spectrometry in a Human Mass Balance and Pharmacokinetic Study–Experience with14C-labeled (R)-6-[Amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a Farnesyl Transferase Inhibitor 2002 ·Drug Metabolism and Disposition ·R. Colin Garner,(unknown),Annouschka Laenen,(unknown),W. Meuldermans,S A Gregory,John Garner,David Tai Leong,(unknown),(unknown),(unknown)	52
3	Comparison of the Absorption of Micronized (Daflon 500® mg) and Nonmicronized 14C‐diosmin Tablets After Oral Administration to Healthy Volunteers by Accelerator Mass Spectrometry and Liquid Scintillation Counting 2002 ·Journal of Pharmaceutical Sciences ·R. Colin Garner,John Garner,S A Gregory,(unknown),(unknown),David Tai Leong	59
4	Postural change of forced vital capacity predicts some respiratory symptoms in ALS 2001 ·Neurology ·J.D. Varrato,Andrew Siderowf,Peter C. Damiano,S A Gregory,David A. Feinberg,Leo McCluskey	59
5	Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. 1996 ·The Journal of Experimental Medicine ·Joseph P. Portanova,(unknown),Graham Anderson,Scott D. Hauser,Jaime L. Masferrer,Karen Seibert,S A Gregory,Peter C. Isakson	359
6	Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. 1996 ·Journal of Clinical Investigation ·Graham Anderson,Scott D. Hauser,(unknown),(unknown),Peter C. Isakson,S A Gregory	481
7	ChemInform Abstract: 1,2‐Diarylcyclopentenes as Selective Cyclooxygenase‐2 Inhibitors and Orally Active anti‐Inflammatory Agents. 1996 ·ChemInform ·(unknown),Graham Anderson,Earl G. Burton,J. Nita Cogburn,Joe Collins,Daniel J. Garland,S A Gregory,Hechang Huang,Peter C. Isakson,Carol M. Koboldt,Eugene W. Logusch,(unknown),William E. Perkins,Emily J. Reinhard,Karen Seibert,Amy W. Veenhuizen,(unknown),David B. Reitz	4
8	T cell activation is regulated by voltage-dependent and calcium-activated potassium channels 1996 ·The Journal of Immunology ·Randall K. Rader,(unknown),(unknown),(unknown),K Chinn,S A Gregory	52
9	A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2) 1995 ·Inflammation Research ·Rita M. Huff,Claire Collins,Søren Kramer,Karen Seibert,Carol M. Koboldt,S A Gregory,Peter C. Isakson	23
10	ChemInform Abstract: Selective Cyclooxygenase Inhibitors: Novel 4‐Spiro 1,2‐ Diarylcyclopentenes are Potent and Orally Active COX‐2 Inhibitors. 1995 ·ChemInform ·David B. Reitz,Hechang Huang,(unknown),Daniel J. Garland,R. Manning,Graham Anderson,S A Gregory,Carol M. Koboldt,William E. Perkins,Karen Seibert,Peter C. Isakson	1
11	An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1 1992 ·Journal of Virology ·Ronald G. Collman,John W. Balliet,S A Gregory,Henry L. Friedman,Dennis L. Kolson,Neal Nathanson,Abhay Srinivasan	320
12	Multichain structure of the IFN-alpha receptor on hematopoietic cells 1992 ·The Journal of Immunology ·O R Colamonici,Lawrence M. Pfeffer,F D'Alessandro,Leonidas C. Platanias,S A Gregory,(unknown),RP Nordan,Ricardo A. Cruciani,MO Diaz	68
13	Chylothorax secondary to obstruction of the superior vena cava: a complication of the LeVeen shunt. 1990 ·Thorax ·William H. Warren,(unknown),S A Gregory	16
14	Characterization of three monoclonal antibodies that recognize the interferon alpha 2 receptor. 1990 ·Proceedings of the National Academy of Sciences ·O R Colamonici,F D'Alessandro,MO Diaz,S A Gregory,L M Neckers,RP Nordan	47
15	Regulation of Tissue Factor Gene Expression in the Monocyte Procoagulant Response to Endotoxin† 1989 ·Molecular and Cellular Biology ·S A Gregory,James H. Morrissey,Thomas S. Edgington	67
16	Tissue factor regulation and gene organization. 1989 ·PubMed ·James H. Morrissey,S A Gregory,Nigel Mackman,T S Edgington	16
17	Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. 1989 ·Molecular and Cellular Biology ·S A Gregory,James H. Morrissey,Thomas S. Edgington	260
18	Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells. 1988 ·The Journal of Immunology ·Richard S. Kornbluth,S A Gregory,T S Edgington	17
19	Cloning of a restriction-modification system from Proteus vulgaris and its use in analyzing a methylase-sensitive phenotype in Escherichia coli 1985 ·Journal of Bacteriology ·Robert Blumenthal,S A Gregory,(unknown)	121
20	Resistance of bovine colostral anti-cholera toxin antibody to in vitro and in vivo proteolysis 1984 ·Infection and Immunity ·Richard E. McClead,S A Gregory	25

About S A Gregory

S A Gregory is a scholar working on Pharmacology, Immunology and Hematology, having authored 22 papers that have together received 2.2k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (6 papers), Macrophage Migration Inhibitory Factor (3 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Virology (318 citations), Hematology (336 citations) and Pharmacology (495 citations). S A Gregory has collaborated with scholars based in United States, United Kingdom and Finland. Frequent co-authors include Thomas S. Edgington, Peter C. Isakson, Graham Anderson, Scott D. Hauser, James H. Morrissey, Karen Seibert, Neal Nathanson, John W. Balliet, Abhay Srinivasan and Henry L. Friedman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact